Revision History

1 revisions for "The Pill in the Mail: How a Federal Court Ruling Could Reshape Abortion Access Across America"

On May 1, 2026, the U.S. Fifth Circuit Court of Appeals temporarily reinstated in-person dispensing requirements for mifepristone, effectively blocking mail-order and telehealth access to the abortion pill nationwide. The ruling in Louisiana v. FDA affects an estimated 30% of all U.S. abortions now provided via telehealth, raises questions about FDA regulatory authority, and sets up a likely Supreme Court confrontation over medication abortion access.